{"code":"E13.2","type":"code","title":"Other specified diabetes mellitus with kidney complications","codeAlso":[],"includes":["diabetes mellitus due to genetic defects of beta-cell function","diabetes mellitus due to genetic defects in insulin action","postpancreatectomy diabetes mellitus","postprocedural diabetes mellitus","secondary diabetes mellitus NEC"],"modern_v":"official26","codeFirst":[],"excludes1":["diabetes (mellitus) due to autoimmune process (E10.-)","diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction (E10.-)","diabetes mellitus due to underlying condition (E08.-)","drug or chemical induced diabetes mellitus (E09.-)","gestational diabetes (O24.4-)","neonatal diabetes mellitus (P70.2)","type 1 diabetes mellitus (E10.-)"],"excludes2":[],"isBillable":false,"sibling_codes":["E13.21","E13.22","E13.29"],"inclusionTerms":[],"sibling_titles":{"code":"E13.29","title":"Other specified diabetes mellitus with other diabetic kidney complication","isBillable":true},"useAdditionalCode":["code to identify control using:","injectable non-insulin antidiabetic drugs (Z79.85)","insulin (Z79.4)","oral antidiabetic drugs (Z79.84)","oral hypoglycemic drugs (Z79.84)"],"clinicalDefinition":"Other specified diabetes mellitus with kidney complications is a non-billable ICD-10-CM category code (E13.2). A more specific billable subcode must be selected for claims submission. Includes: diabetes mellitus due to genetic defects of beta-cell function; diabetes mellitus due to genetic defects in insulin action; postpancreatectomy diabetes mellitus; postprocedural diabetes mellitus; secondary diabetes mellitus NEC.","officialDefinition":"Other specified diabetes mellitus with kidney complications is a non-billable ICD-10-CM category code (E13.2). A more specific billable subcode must be selected for claims submission. Includes: diabetes mellitus due to genetic defects of beta-cell function; diabetes mellitus due to genetic defects in insulin action; postpancreatectomy diabetes mellitus; postprocedural diabetes mellitus; secondary diabetes mellitus NEC. Excludes1 (not coded here): diabetes (mellitus) due to autoimmune process (E10.-); diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction (E10.-); diabetes mellitus due to underlying condition (E08.-); drug or chemical induced diabetes mellitus (E09.-); gestational diabetes (O24.4-); neonatal diabetes mellitus (P70.2); type 1 diabetes mellitus (E10.-). Use additional code: code to identify control using:; injectable non-insulin antidiabetic drugs (Z79.85); insulin (Z79.4); oral antidiabetic drugs (Z79.84); oral hypoglycemic drugs (Z79.84).","seventhCharacterInstructions":[],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":""}